Evidence map›Paper›PMID 40108108›Full record

ArticleNature communications2025

TopEC: prediction of Enzyme Commission classes by 3D graph neural networks and localized 3D protein descriptor.

Karel van der Weg, Erinc Merdivan, Marie Piraud, Holger Gohlke

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Technical review of artificial intelligence in TCR-T therapy.Journal of the National Cancer Center · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Artificial Intelligence Powers Protein Functional Annotation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Karel van der WegInstitute of Bio- and Geosciences (IBG-4: Bioinformatics), Forschungszentrum Jülich GmbH, 52425, Jülich, Germany.ORCID http://orcid.org/0000-0002-1896-0291
Erinc MerdivanHelmholtz AI Central Unit, Ingolstädter Landstraße 1, 85764, Oberschleißheim, Germany.
Marie PiraudHelmholtz AI Central Unit, Ingolstädter Landstraße 1, 85764, Oberschleißheim, Germany.ORCID http://orcid.org/0000-0002-4917-2458
Holger GohlkeInstitute of Bio- and Geosciences (IBG-4: Bioinformatics), Forschungszentrum Jülich GmbH, 52425, Jülich, Germany. h.gohlke@fz-juelich.de.ORCID http://orcid.org/0000-0001-8613-1447

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tools available for inferring enzyme function from general sequence, fold, or evolutionary information are generally successful. However, they can lead to misclassification if a deviation in local structural features influences the function. Here, we present TopEC, a 3D graph neural network based on a localized 3D descriptor to learn chemical reactions of enzymes from enzyme structures and predict Enzyme Commission (EC) classes. Using message-passing frameworks, we include distance and angle information to significantly improve the predictive performance for EC classification (F-score: 0.72) compared to regular 2D graph neural networks. We trained networks without fold bias that can classify enzyme structures for a vast functional space (>800 ECs). Our model is robust to uncertainties in binding site locations and similar functions in distinct binding sites. We observe that TopEC networks learn from an interplay between biochemical features and local shape-dependent features. TopEC is available as a repository on GitHub: https://github.com/IBG4-CBCLab/TopEC and https://doi.org/10.25838/d5p-66 .

Indexed as

Computational BiologyEnzymesNeural Networks, ComputerAlgorithmsBinding SitesGraph Neural NetworksProtein ConformationSoftwareEnzymes

Identifiers

PMID40108108
PMCPMC11923149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.